Rare Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with primary hyperoxaluria (a rare genetic condition affecting how the body processes oxalate)
- You have been diagnosed with enteric hyperoxaluria (high oxalate levels in the urine caused by digestive system issues)
- You have been diagnosed with Dent Disease (a rare kidney condition affecting mostly males)
- You have been diagnosed with Cystinuria (a condition where too much of an amino acid called cystine builds up in the kidneys)
- You have been diagnosed with adenine phosphoribosyltransferase deficiency, also called APRTd (a rare inherited condition that can cause kidney stones)
- You have been diagnosed with Lowe Syndrome (a rare genetic condition affecting the eyes, brain, and kidneys)
- You have been identified as a carrier of Dent Disease (meaning you carry the gene for Dent Disease but may not have all the symptoms)
Who may not be able to join:
- You have previously experienced kidney failure
- You have had a liver transplant and/or a kidney transplant in the past
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: John Lieske, MD, Mayo Clinic
Phone: 800-270-4637
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
inflammatory blood and urinary biomarkers
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.